On 19 June 2024, the exercise period for warrants of series TO 3, which were issued in connection with Carbiotix's rights issue of units earlier in 2024, ended. As a result of the warrant exercise, 20,796,181 new shares have now been registered with the Swedish Companies Registration Office. The total number of shares in the Company after the exercise of warrants of series TO 3 amounts to 201,022,976 and the share capital amounts to SEK 3,015,344.64.

Conversion of interim shares to ordinary shares takes place around 5 July 2024 and the new shares are expected to be available on each subscriber's account around 9 July 2024.

For more information about the TO 3, please contact:
Sedermera Corporate Finance AB
Tel: +46 (0)40 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se

For more information, please contact:
Erik Deaner, VD
Telefon: +46 (0)73-867 30 85
E-post: erik.deaner@carbiotix.com

About Carbiotix
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through upcycled prebiotics. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into functional products.